PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Intense research effort in low-temperature (or cold) atmospheric plasma application in bioengineering led to foundation of a new field, plasma medicine. Cold atmospheric plasmas (CAP) produce chemically reactive species including reactive oxygen species (ROS) and reactive nitrogen species (RNS). These species are known to have biological effects on prokaryotic and eukaryotic cells, such as the peroxidation of lipids and proteins. The most recent research area of plasma medicine is the interaction of CAP with cancer cells. It has been demonstrated by several investigators that CAP can induce apoptosis (programmed cell death) in various cancer cell lines. In addition, CAP treatment affects preferentially the cell cycle of cancer cells. This opened up the possibility that CAP could be the basis of a new cancer therapy. The uniqueness of low-temperature plasma is in its ability to change composition in situ. The above mentioned biomedical applications seem to usher a new transformational approach to healthcare based on CAP technology. In this presentation a review of the research achievements accomplished in the last decade will be presented.
Michael Keidar
"Plasma medicine: past, present, and future", Proc. SPIE PC12843, Biophotonics and Immune Responses XIX, PC128430C (13 March 2024); https://doi.org/10.1117/12.3004224
ACCESS THE FULL ARTICLE
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Michael Keidar, "Plasma medicine: past, present, and future," Proc. SPIE PC12843, Biophotonics and Immune Responses XIX, PC128430C (13 March 2024); https://doi.org/10.1117/12.3004224